Treatment-related fatigue - Causes, Treatment & When to See a Doctor

```html

What is Treatment‑Related Fatigue?

Treatment‑related fatigue (TRF) is a persistent sense of tiredness or lack of energy that develops during or after medical therapy—most often chemotherapy, radiation, immunotherapy, or targeted agents used for cancer or chronic inflammatory diseases. Unlike ordinary tiredness, TRF is disproportionate to the level of activity performed, does not improve substantially with rest, and can interfere with daily functioning, work, and quality of life.

TRF is a multidimensional problem that involves physical, emotional, and metabolic components. The exact mechanisms are not fully understood, but research points to a combination of anemia, inflammatory cytokine release, hormonal changes, mitochondrial dysfunction, and psychosocial stressors.<sup>1</sup>

Common Causes

While the term “treatment‑related” implies a link to therapy, several distinct conditions can trigger fatigue in this context:

• Chemotherapy‑induced anemia – Bone‑marrow suppression lowers hemoglobin, reducing oxygen delivery to muscles.
• Radiation therapy – Particularly when large fields (e.g., whole‑brain or pelvic) are treated, inflammation and tissue damage increase fatigue.
• Immunotherapy (checkpoint inhibitors) – Cytokine release can cause systemic malaise.
• Targeted therapy (tyrosine‑kinase inhibitors, hormonal agents) – Off‑target effects on the endocrine system disturb sleep and energy.
• Concurrent endocrine disorders – Hypothyroidism or adrenal insufficiency induced by steroids or radiation.
• Metabolic imbalances – Electrolyte disturbances, low vitamin D, or iron deficiency.
• Infection – Neutropenia or mucositis can lead to subclinical infections that drain energy.
• Pain or neuropathy – Chronic discomfort forces the patient to limit activity, worsening de‑conditioning.
• Depression or anxiety – Psychological distress amplifies perceived fatigue.
• Sleep‑disordered breathing – Opioids, steroids, or weight gain from treatment can precipitate obstructive sleep apnea.

Associated Symptoms

TRF rarely appears in isolation. The following symptoms often accompany it, helping clinicians differentiate it from simple tiredness:

• Weakness or reduced muscle strength
• Difficulty concentrating (“brain fog”)
• Insomnia or fragmented sleep
• Loss of appetite, nausea, or taste changes
• Shortness of breath with minimal exertion
• Depressive mood, irritability, or anxiety
• Pain, neuropathy, or joint stiffness
• Weight loss or unexpected weight gain
• Fever, chills, or signs of infection

When to See a Doctor

Because fatigue can signal serious complications, patients should schedule an evaluation promptly if they experience any of the following:

• Fatigue that worsens over days or weeks rather than improves with rest
• New or rapidly increasing shortness of breath
• Chest pain, palpitations, or irregular heartbeat
• Persistent fever (>100.4°F / 38°C) or recurrent infections
• Sudden weight loss (>5 % of body weight in a month)
• Marked changes in mood, thoughts of hopelessness, or suicidal ideation
• Severe nausea, vomiting, or difficulty staying hydrated
• Signs of anemia (pallor, dizziness, rapid heartbeat)

Diagnosis

Diagnosing TRF involves a systematic approach to rule out reversible medical causes, assess treatment impact, and evaluate functional status.

Step 1 – Detailed History

• Onset, duration, and pattern of fatigue relative to treatment cycles
• Medication review (including over‑the‑counter supplements)
• Sleep habits, diet, activity level, and psychosocial stressors

Step 2 – Physical Examination

• Vital signs (especially temperature and heart rate)
• Cardiac and pulmonary auscultation
• Assessment for pallor, edema, cachexia, or infection sites

Step 3 – Laboratory Tests

• Complete blood count (CBC) with differential – to detect anemia, neutropenia, or thrombocytopenia
• Comprehensive metabolic panel – liver/kidney function, electrolytes
• Thyroid‑stimulating hormone (TSH) and free T4 – screen for hypothyroidism
• Ferritin, iron studies, vitamin B12, and vitamin D levels
• C‑reactive protein (CRP) or erythrocyte sedimentation rate (ESR) – evaluate inflammation

Step 4 – Specialized Tests (if indicated)

• Chest X‑ray or CT to rule out pulmonary infection or disease progression
• Polysomnography for suspected sleep apnea
• Cardiac stress test or echocardiogram if cardiac causes are suspected
• Psychological screening tools (PHQ‑9, GAD‑7) for depression/anxiety

Step 5 – Functional Assessment

Validated questionnaires such as the Brief Fatigue Inventory (BFI) or the Functional Assessment of Cancer Therapy–Fatigue (FACT‑F) help quantify severity and impact on daily life.

Treatment Options

Management is individualized, targeting the underlying cause(s) while also providing symptom‑relief strategies.

Medical Interventions

• Correct anemia – Blood transfusions, erythropoiesis‑stimulating agents, or iron supplementation when indicated.
• Thyroid hormone replacement – Levothyroxine for hypothyroidism.
• Growth factor support – G‑CSF for neutropenia‑related fatigue.
• Medication adjustment – Dose reduction or schedule change for agents known to cause fatigue (e.g., high‑dose steroids, certain TKIs).
• Antidepressants or anxiolytics – SSRIs/SNRIs improve mood‑related fatigue when depression is present.
• Pain control – Optimizing analgesia (non‑opioid first line, nerve blocks, gabapentinoids) reduces energy drain.

Non‑pharmacologic Strategies

• Exercise prescription – Light‑to‑moderate aerobic activity (walking, stationary cycling) 2–3 times per week has the strongest evidence for reducing cancer‑related fatigue (Cochrane Review, 2022). Start with 5‑10 minutes and gradually increase.
• Energy conservation – Teach pacing, prioritize essential tasks, and rest before fatigue becomes overwhelming.
• Sleep hygiene – Fixed bedtime, limit caffeine/alcohol, use a dark, cool room, and consider short‑term melatonin (3 mg) if sleep onset is delayed.
• Nutritional support – Small, frequent, protein‑rich meals; consider oral nutrition supplements if intake is poor.
• Psychosocial interventions – Cognitive‑behavioral therapy (CBT), mindfulness‑based stress reduction, or support groups improve coping and reduce perceived fatigue.
• Hydration – Aim for ≥2 L of fluid daily unless contraindicated; dehydration worsens fatigue.
• Complementary approaches – Acupuncture and yoga have modest benefit in trials; discuss with the oncology team to avoid drug interactions.

Prevention Tips

While not all fatigue can be avoided, the following measures can lower risk before it becomes severe:

• Baseline assessment – Conduct labs and functional screening before starting therapy to identify correctable deficits.
• Proactive anemia management – Use iron or erythropoietin early in patients with baseline low hemoglobin.
• Maintain regular activity – Even low‑intensity movement (stretching, short walks) before treatment helps preserve endurance.
• Balanced diet – Emphasize lean protein, whole grains, fruits, and vegetables; limit processed foods.
• Sleep schedule – Establish consistent bedtime/wake‑time even during hospital stays.
• Medication review – Discuss with the prescribing clinician any drugs that may exacerbate fatigue (e.g., high‑dose steroids, antihistamines).
• Stress management – Early referral to counseling or stress‑reduction programs.
• Vaccinations & infection prophylaxis – Prevent infections that can precipitate fatigue (e.g., flu shot, pneumococcal vaccine).

Emergency Warning Signs

---

**References**

1. National Cancer Institute. Cancer‑related fatigue (PDQ®) – Health Professional Version. Updated 2023. https://www.cancer.gov/about-cancer/managing-care/symptoms/fatigue
2. Mayo Clinic. Fatigue during cancer treatment. 2022. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/fatigue/art-20046488
3. American Society of Clinical Oncology. Managing Cancer‑Related Fatigue. 2023. https://www.asco.org
4. Cochrane Database of Systematic Reviews. Exercise for cancer‑related fatigue. 2022. DOI:10.1002/14651858.CD006100
5. World Health Organization. WHO guidelines on physical activity and sedentary behaviour. 2020. https://www.who.int/publications/i/item/9789240015128

```